Clovis Oncology to Announce Fourth Quarter/Full Year 2019 Financial Results and Host Webcast Conference Call on February 24
February 13 2020 - 8:30AM
Business Wire
Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its fourth
quarter and full year 2019 financial results on Monday, February
24, 2020, after the close of the U.S. financial markets. Clovis’
senior management will host a conference call and live audio
webcast at 4:30 p.m. ET to discuss the company’s results in greater
detail.
The conference call is being webcast and can be accessed from
the Clovis Oncology website at www.clovisoncology.com. A replay of
the webcast will be available for 30 days.
Conference Call Details
Clovis will hold a conference call to discuss fourth quarter and
full year 2019 results on Monday, February 24 at 4:30 p.m. ET. The
conference call will be simultaneously webcast on the Company’s web
site at www.clovisoncology.com, and archived for future review.
Dial-in numbers for the conference call are as follows: US
participants (866) 393-4306, International participants (734)
385-2616, conference ID: 1255036.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on
acquiring, developing and commercializing innovative anti-cancer
agents in the U.S., Europe and additional international markets.
Clovis Oncology targets development programs at specific subsets of
cancer populations, and simultaneously develops, with partners,
diagnostic tools intended to direct a compound in development to
the population that is most likely to benefit from its use. Clovis
Oncology is headquartered in Boulder, Colorado; please visit
www.clovisoncology.com for more information, including additional
office locations in the U.S. and Europe.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200213005101/en/
Clovis Investor Contacts: Anna Sussman 303.625.5022
asussman@clovisoncology.com Breanna Burkart 303.625.5023
bburkart@clovisoncology.com
Clovis Oncology (NASDAQ:CLVS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Clovis Oncology (NASDAQ:CLVS)
Historical Stock Chart
From Apr 2023 to Apr 2024